In vitro susceptibility of Streptococcus pyogenes strains recently isolated from pharyngotonsillitis in France

被引:9
|
作者
Cohen, R
Fremaux, A
DeGouvello, A
Deforche, V
Levy, C
Wadbled, D
DeLaRocque, E
Varon, E
Geslin, P
机构
来源
MEDECINE ET MALADIES INFECTIEUSES | 1996年 / 26卷 / 8-9期
关键词
Streptococcus pyogenes; group A streptococci; pharyngotonsillitis; antibiotic susceptibility; minimum inhibitory concentration; penicillin; ampicillin; cephalosporin; macrolide;
D O I
10.1016/S0399-077X(96)80032-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Between November 1995 and May 1996, 173 French general practitioners conducted an epidemiologic survey to evaluate the susceptibility of Streptococcus pyogenes isolated from acute pharyngotonsillitis. 2800 adults and children over 4 years of age were enrolled. Among them, 393 had positive rapid strep tests (Testpack plus Strep A(R), Abbott), 375 underwent bacteriological sample for culture. 324 Streptococcus pyogenes were isolated and the predictive positive value of the test was 86.4 %. The minimum inhibitory concentrations (MIC) of several oral antibiotics were determined by the agar dilution method. All 324 strains were susceptible to penicillin, ampicillin, cefaclor (concentration of antibiotic required to inhibit 90 % of isolates, respectively, 0.016, 0.032, 0.5 mu gr/ml). For erythromycin, 94.5 % (306/324) of tested strains were susceptible, 18 had MIC of 2 mu gr/ml or greater (MIC between 2 and 4 mu gr/ml for 10 isolates and MIC greater than or equal to 8 mu gr/ml for 8 isolates).
引用
收藏
页码:765 / 769
页数:5
相关论文
共 50 条
  • [41] Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010
    Tali-Maamar, H.
    Laliam, R.
    Bentchouala, C.
    Touati, D.
    Sababou, K.
    Azrou, S.
    Azzam, M.
    Amhis, W.
    Oussadou, L.
    Belouni, R.
    Smati, F.
    Rahal, K.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (02): : 59 - 65
  • [42] In vitro bactricidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized children
    Regev-Yochay, Gili
    Malley, Richard
    Rubinstein, Ethan
    Raz, Meir
    Dagan, Ron
    Lipsitch, Marc
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) : 747 - 749
  • [43] TRANSFER OF ERYTHROMYCIN RESISTANCE FROM CLINICALLY ISOLATED LYSOGENIC STRAINS OF STREPTOCOCCUS-PYOGENES VIA THEIR ENDOGENOUS PHAGE
    HYDER, SL
    STREITFELD, MM
    JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (03): : 281 - 286
  • [44] In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999
    Schlegel, L
    Merad, B
    Rostane, H
    Broc, V
    Bouvet, A
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (07) : 362 - 366
  • [45] Molecular analysis of Streptococcus pyogenes strains isolated from patients with recurrent pharyngitis after oral amoxicillin treatment
    Saito, Mitsumasa
    Hirose, Mizuo
    Ichinose, Hirofumi
    Villanueva, Sharon Y. A. M.
    Yoshida, Shin-ichi
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (11) : 1544 - 1550
  • [46] Characterization of IdeS of M1 and M12 from Clinical Isolated Streptococcus pyogenes Strains
    Su, Y.
    Wu, M.
    Chuang, W.
    Wang, S.
    Lin, Y.
    Wu, J.
    Lin, M.
    Liu, C.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17
  • [47] Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia
    Ksia, Sonia
    Smaoui, Hanen
    Hraoui, Manel
    Bouafsoun, Aida
    Boutiba-Ben Boubaker, Ihem
    Kechrid, Amel
    MICROBIAL DRUG RESISTANCE, 2017, 23 (05) : 633 - 639
  • [48] Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland:: the in vitro activity of telithromycin versus comparators
    Shackcloth, J
    Williams, L
    Farrell, DJ
    JOURNAL OF INFECTION, 2004, 48 (03) : 229 - 235
  • [49] Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in japan from patients with severe invasive group a streptococcal infections
    Ikebe, T
    Hirasawa, K
    Suzuki, R
    Isobe, J
    Tanaka, D
    Katsukawa, C
    Kawahara, R
    Tomita, M
    Ogata, K
    Endoh, M
    Okuno, R
    Watanabe, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 788 - 790
  • [50] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Betriu, C
    Culebras, E
    Redondo, M
    Rodríguez-Avial, I
    Gómez, M
    Boloix, A
    Picazo, JJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 436 - U11